510(k) DEN240068

ArteraAI Prostate by Artera, Inc. — Product Code SFH

Clearance Details

Decision
DENG (De Novo Granted)
Decision Date
July 31, 2025
Date Received
November 25, 2024
Clearance Type
Direct
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Pathology Software Algorithm Device Analyzing Digital Images For Cancer Prognosis
Device Class
Class II
Regulation Number
864.3755
Review Panel
PA
Submission Type

A pathology software algorithm device analyzing digital images for cancer prognosis is a software intended to analyze scanned whole slide images (WSIs) from prostate biopsies prepared from formalin fixed paraffin-embedded (FFPE) tissue and stained using Hematoxylin & Eosin (H&E) stains. The device provides prognostic risk estimates which are intended to assist physicians with prognostic risk-based decisions along with other clinicopathological factors. The device is not intended to determine a clinical diagnosis.